Site Members can sign up for company wide alerts
Lawsuit Overview
September 29, 2023 - An amended complaint was filed. April 28, 2023 - An investor in shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Fulcrum Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between March 3, 2022...
You must register (for free) or login to view the entire case.